Combining covariate adjustment with information from secondary endpoints to improve precision in randomized trials
结合协变量调整与次要终点信息提高随机试验精度AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要围绕随机试验主要终点的平均处理效应及其精度展开。
结合协变量调整与次要终点信息提高随机试验精度AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
Background/Aims: Adjustment for prognostic baseline covariates can improve precision in randomized trials. Previous work has shown that jointly modeling primary and secondary endpoints can yield additional precision by borrowing information across endpoints. We investigated whether these approaches can be combined to achieve efficiency gains beyond those obtained through covariate adjustment alone. Methods: We extended a previously proposed one-factor structural equation modeling framework for borrowing information from secondary endpoints to incorporate baseline covariates while retaining the average treatment effect on the primary endpoint as the estimand. To mitigate sensitivity to model misspecification, we combined this estimator with a conventional covariate-adjusted estimator using cross-validated model averaging. We evaluated operating characteristics in simulations and applied the methods to a randomized trial of very low versus normal nicotine content cigarettes. Results: When the structural equation model was correctly specified, endpoint borrowing improved efficiency beyond conventional covariate adjustment across all simulated settings. Model misspecification could induce bias and undercoverage. Model averaging reduced bias and improved coverage relative to the structural equation model estimator, although coverage remained imperfect under severe misspecification. In the trial application, the model-averaged estimate was 21% more precise than the unadjusted estimate and 13% more precise than covariate adjustment alone. Conclusion: Secondary endpoints can contribute meaningful information about the average treatment effect on a primary endpoint even after baseline covariates have been incorporated. These gains require stronger assumptions than conventional covariate adjustment; model averaging provides a practical compromise between efficiency and robustness.